METHOD OF SYNTHESIS OF PEPTIDEAMIDE DERIVATIVES OR THEIR PHYSIOLOGICALLY COMPATIBLE ACETATES OR HYDROCHLORIDES Russian patent published in 1995 - IPC

Abstract RU 2036200 C1

FIELD: peptide chemistry. SUBSTANCE: product: derivatives of peptideamides of the formula (I) (X)n-A-NH2 where X - Ac-L (or D)-(Hal), p-Cl-L (or D)-Phe, L (or D)-Ser, L (or D)-Tyr, L (or D)-Trp, L (or D)-Ser(α-L-Phe), L (or D)-Leu, L (or D)-Arg, L (or D)-Pro, p-Slu, His, D-Ser(t-Bu); n = 3-10; A - azaglycine, or their biologically compatible acetates or hydrochlorides. Reagent 1: compound of the formula (II) where Y1-Y5 - hydrogen; C1-C4-alkoxy-group; -(CH2)m-C(O)-OH [radicals are similar or different but at least one of their is (CH2)n-C(O)-OH]; m = 1-3; R1 - hydrogen; 4-methoxyphenyl. Reagent 2: silyling agent of the group: tert.-butyldimethylsilyl chloride, tert.-butylphenylsilyl chloride, trimethylchlorosilane, bis-trimethylsilylacetamide. Reaction conditions: process is carried out in the medium of solvent following by treatment of silylated compound with chloroformic acid derivative. Compounds of the formula (III) R2 were prepared where Y1-Y5 and R1 - as indicated above; R2 - halogeno (or nitro)-phenyl. These compounds were treated with hydrazide hydrochloride R3-protected with corresponding α-amino acid (X meaning) where R3, Fmoc Bpoc, BOC - are protective groups, in the medium of solvent with formation of compound of the formula (IV) . Protective group -BOC- is removed by hydrogenation on the Pt-catalyst. Before the further reaction protective group is conversed to the Fmoc- or BOC-protective group. Then compounds of the formula (IV) (at meaning R3 - Fmoc, Bpoc-urethane-protective group) were copulated using usual peptide reagent (through -(CH)n-C(O)-OH-grouping on the resin), protective group R3 is split, and then step by step Fmoc- or Bpoc-protected α-amino acids (in some cases in the form of activated derivatives) were joined. After synthesis termination of peptide of the formula (I) the latter is released from resin by treatment with moderate force acid. Simultaneously or using conventional procedures temporarily added side chain protective groups were split. EFFECT: improved method of synthesis.

Similar patents RU2036200C1

Title Year Author Number
PEPTIDES AND THEIR PHYSIOLOGICALLY ACCEPTABLE SALTS 1992
  • Shtefan Khenke[De]
  • Khiristo Anagnoshtopulos[De]
  • Gerkhard Brajpol'[De]
  • Jokhen Knolle[De]
  • Jens Shtekhl'[De]
  • Bernvard Shel'Kens[De]
RU2083586C1
PEPTIDE DERIVATIVES 1992
  • Shtefan Khenke[De]
  • Gerkhard Brajpol'[De]
  • Jokhen Knolle[De]
  • Bernvard Shel'Kens[De]
  • Khermann Gerkhards[De]
RU2081880C1
NEUROMEDIN AND SOMATOSTATIN RECEPTOR AGONISTS 2000
  • Sadat-Aalai Din
  • Morgan Barri A.
RU2263680C2
PTH-COMPOUNDS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION CONTAINING THEIR, DNA FRAGMENT AND FUSED PROTEIN 1993
  • Bauehr Vilfrid
  • Brekenridzh Robin
  • Kardino Fransua
  • Gombert Frank
  • Gram Germann
  • Rehmehdzh Pol
  • Shnajder Gel'Mut
  • Vaehl'Khli Rudol'F
  • Al'Bert Rajner
  • Ljuis Jan
RU2130945C1
CYCLOHEXAPEPTIDES, MIXTURES THEREOF, AND METHOD OF PREPARING THEREOF 1995
  • Shtefan Khenke
  • Birgit Zhordan
  • Jokhen Knolle
  • Leander Laufer
  • Suzanne Fajertag
  • Kharl-Khajnts Vismjuller
  • Gjunter Jung
RU2163242C2
ANALOGUES OF PEPTIDE LH-RF, THEIR APPLICATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF 1998
  • Deljansorn Remi
  • Pari Zhak
RU2212247C2
METHOD OF SOLID-PHASE PEPTIDE SYNTHESIS 1991
  • Dzhon Dzhozef Nestor
  • Natali Levis Makkljur[Us]
  • Khumberto Arzeno[Ar]
RU2043362C1
PEPTIDE COMPOSITIONS 2014
  • Sharma Shubkh
  • Van Der Plug Leonardus Kh.T.
  • Khenderson Bart
RU2725150C2
METASTIN DERIVATIVES AND APPLICATION THEREOF 2006
  • Asami Taidzi
  • Nisizava Naoki
RU2430107C2
METASTIN DERIVATIVES AND USE THEREOF 2007
  • Asami Taidzi
  • Nisizava Naoki
RU2454425C2

RU 2 036 200 C1

Authors

Gerkhard Brajpol'[De]

Jokhen Knolle[De]

Vol'Fgang Kenig[De]

Dates

1995-05-27Published

1991-08-29Filed